The presence of HLA-B*5701, -DRB1*0701 and -DQ3 is highly predictive of hypersensitivity to the HIV reverse transcriptase inhibitor abacavir

S. Mallal; C. Witt; A.M. Martin; G. Masel; C. Moore; D. Sayer; A. Castley; C. Mamotte; D. Nolan; I. James; Frank Christiansen

The presence of HLA-B5701, -DRB10701 and -DQ3 is highly predictive of hypersensitivity to the HIV reverse transcriptase inhibitor abacavir

S. Mallal
, C. Witt
, A.M. Martin
, G. Masel
, C. Moore
, D. Sayer
, A. Castley
, C. Mamotte
, D. Nolan
, I. James
, Frank Christiansen

Graduate Research School

Research output: Chapter in Book/Conference paper › Conference paper

Original language	English
Title of host publication	XIII International Congress of Histocompatibility and Immunogenetics
Editors	J. McCluskey
Place of Publication	Copenhagen, Denmark
Publisher	Blackwell
Pages	33
Volume	59, Supplement 2
Edition	Seattle, WA, USA
ISBN (Print)	00012815
Publication status	Published - 2002
Event	The presence of HLA-B5701, -DRB10701 and -DQ3 is highly predictive of hypersensitivity to the HIV reverse transcriptase inhibitor abacavir - Seattle, WA, USA Duration: 1 Jan 2002 → …

Conference

Conference	The presence of HLA-B5701, -DRB10701 and -DQ3 is highly predictive of hypersensitivity to the HIV reverse transcriptase inhibitor abacavir
Period	1/01/02 → …

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

Mallal, S., Witt, C., Martin, A. M., Masel, G., Moore, C., Sayer, D., Castley, A., Mamotte, C., Nolan, D., James, I., & Christiansen, F. (2002). The presence of HLA-B*5701, -DRB1*0701 and -DQ3 is highly predictive of hypersensitivity to the HIV reverse transcriptase inhibitor abacavir. In J. McCluskey (Ed.), XIII International Congress of Histocompatibility and Immunogenetics (Seattle, WA, USA ed., Vol. 59, Supplement 2, pp. 33). Blackwell.

Mallal, S. ; Witt, C. ; Martin, A.M. et al. / The presence of HLA-B*5701, -DRB1*0701 and -DQ3 is highly predictive of hypersensitivity to the HIV reverse transcriptase inhibitor abacavir. XIII International Congress of Histocompatibility and Immunogenetics. editor / J. McCluskey. Vol. 59, Supplement 2 Seattle, WA, USA. ed. Copenhagen, Denmark : Blackwell, 2002. pp. 33

@inproceedings{71965175d58b40fcbaee9408d63d870a,

title = "The presence of HLA-B*5701, -DRB1*0701 and -DQ3 is highly predictive of hypersensitivity to the HIV reverse transcriptase inhibitor abacavir",

author = "S. Mallal and C. Witt and A.M. Martin and G. Masel and C. Moore and D. Sayer and A. Castley and C. Mamotte and D. Nolan and I. James and Frank Christiansen",

year = "2002",

language = "English",

isbn = "00012815",

volume = "59, Supplement 2",

pages = "33",

editor = "J. McCluskey",

booktitle = "XIII International Congress of Histocompatibility and Immunogenetics",

publisher = "Blackwell",

address = "United Kingdom",

edition = "Seattle, WA, USA",

note = "The presence of HLA-B*5701, -DRB1*0701 and -DQ3 is highly predictive of hypersensitivity to the HIV reverse transcriptase inhibitor abacavir ; Conference date: 01-01-2002",

}

Mallal, S, Witt, C, Martin, AM, Masel, G, Moore, C, Sayer, D, Castley, A, Mamotte, C, Nolan, D, James, I & Christiansen, F 2002, The presence of HLA-B*5701, -DRB1*0701 and -DQ3 is highly predictive of hypersensitivity to the HIV reverse transcriptase inhibitor abacavir. in J McCluskey (ed.), XIII International Congress of Histocompatibility and Immunogenetics. Seattle, WA, USA edn, vol. 59, Supplement 2, Blackwell, Copenhagen, Denmark, pp. 33, The presence of HLA-B*5701, -DRB1*0701 and -DQ3 is highly predictive of hypersensitivity to the HIV reverse transcriptase inhibitor abacavir, 1/01/02.

The presence of HLA-B*5701, -DRB1*0701 and -DQ3 is highly predictive of hypersensitivity to the HIV reverse transcriptase inhibitor abacavir. / Mallal, S.; Witt, C.; Martin, A.M. et al.
XIII International Congress of Histocompatibility and Immunogenetics. ed. / J. McCluskey. Vol. 59, Supplement 2 Seattle, WA, USA. ed. Copenhagen, Denmark: Blackwell, 2002. p. 33.

Research output: Chapter in Book/Conference paper › Conference paper

TY - GEN

T1 - The presence of HLA-B*5701, -DRB1*0701 and -DQ3 is highly predictive of hypersensitivity to the HIV reverse transcriptase inhibitor abacavir

AU - Mallal, S.

AU - Witt, C.

AU - Martin, A.M.

AU - Masel, G.

AU - Moore, C.

AU - Sayer, D.

AU - Castley, A.

AU - Mamotte, C.

AU - Nolan, D.

AU - James, I.

AU - Christiansen, Frank

PY - 2002

Y1 - 2002

M3 - Conference paper

SN - 00012815

VL - 59, Supplement 2

SP - 33

BT - XIII International Congress of Histocompatibility and Immunogenetics

A2 - McCluskey, J.

PB - Blackwell

CY - Copenhagen, Denmark

T2 - The presence of HLA-B*5701, -DRB1*0701 and -DQ3 is highly predictive of hypersensitivity to the HIV reverse transcriptase inhibitor abacavir

Y2 - 1 January 2002

ER -

Mallal S, Witt C, Martin AM, Masel G, Moore C, Sayer D et al. The presence of HLA-B*5701, -DRB1*0701 and -DQ3 is highly predictive of hypersensitivity to the HIV reverse transcriptase inhibitor abacavir. In McCluskey J, editor, XIII International Congress of Histocompatibility and Immunogenetics. Seattle, WA, USA ed. Vol. 59, Supplement 2. Copenhagen, Denmark: Blackwell. 2002. p. 33